Cystic fibrosis is a debilitating genetic disorder that affects nearly 40,000 children and adults in the US. Recent advancements in biotechnology have led to the development of innovative treatments, including gene therapies and CFTR modulators. Companies like Enterprise Therapeutics, Krystal Biotech, Recode Therapeutics, Sionna Therapeutics, and Vertex Pharmaceuticals are at the forefront of this research,…
Biotech on The Soothsayer / page 3
A recent surge in interest in T cell engagers, a type of antibody engineered to redirect the immune system’s T cells to recognize and kill cancer cells, suggests that this field is set to take off. Several biotech companies have launched specifically to develop these medicines, and big names in the industry are investing in…
The biotech industry is witnessing a surge in the development of GPCR (G protein-coupled receptor) therapies, with eight promising biotechs acquiring funding to fortify their pipelines. These biotechs are working on various GPCR-targeted drugs to address numerous diseases, including neuropathic pain, cancer, and metabolic disorders. The market for GPCR drugs is expected to grow significantly,…
Multiple sclerosis is a chronic disease of the central nervous system that affects nearly one million people in the U.S. alone. Biotech companies are working to expand therapeutic options for the disease, which is currently treated with disease-modifying drugs. Several companies, including Biogen, Immunic Therapeutics, Kyverna Therapeutics, Progentos Therapeutics, TG Therapeutics, and Zenas BioPharma, are…
Nanotechnology is transforming the healthcare industry with its potential to revolutionize drug delivery, diagnostics, and treatment of various diseases. Eight companies, including Sona Nanotech, Nanobiotix, and ARIZ Precision Medicine, are at the forefront of this revolution, developing innovative nanotechnology-based solutions for cancer treatment, autoimmune diseases, and other conditions. These companies are leveraging nanotechnology to create…
The biopharma industry is in need of talented minds to take promising pipelines to the clinic and beyond. Venture capitalists have nominated prominent founders and entrepreneurs in the biotech industry who are committed to bringing potentially life-changing treatments to market. These entrepreneurs have proven their expertise in hitting milestones, be it in the lab or…
A new wave of biomimicry companies is harnessing the power of nature to develop innovative treatments for various diseases. By studying the properties of plants and animals, these companies are creating novel therapeutic targets and drugs that mimic natural protective mechanisms. From tick saliva to snake venom, these biomimicry companies are unlocking the secrets of…
The biotech industry has seen a surge in the number of unicorns, with over 1,200 companies worldwide achieving valuations of over $1 billion. However, biotech unicorns are relatively rare, with only a few companies making it to the top. This article takes a closer look at 12 biotech unicorns that are making waves in the…
A recent surge in therapeutic progress has brought new hope to patients suffering from Duchenne muscular dystrophy, a severe form of inherited muscular dystrophy. Several biotech companies, including Wave Life Sciences, Sarepta Therapeutics, Capricor Therapeutics, Edgewise Therapeutics, Italfarmaco, and Avidity Biosciences, are making significant strides in developing innovative treatments, including RNA medicines, gene therapies, and…
Lithuania’s life sciences industry is experiencing a significant boom, with over 550 biotech companies and a growing number of startups. The country is home to several promising ventures, including Atrandi Biosciences, Biomatter Designs, CasZyme, Delta Biosciences, Genie Biotech, and Vital3D, which are pushing the boundaries of protein engineering, gene editing, and microfluidics. This growth is…
